Description: Introduction to additional actuarial research into development of and regulatory impact, economic impact and consumer impact of prescription drugs in the United States. Intended to further educate actuaries and others who work in this area and motivate more actuarial involvement to increase transparency, increase competition, better align stakeholder incentives and better mitigate total cost of care increases

Description: Article reviews the data a year into the unwinding of continuous coverage provisions in Medicaid, the impact on enrollment counts, how capitation rates have been adjusted, and compares those results to what has been modeled with the SOA Mediciad Unwinding model.

Description: State Medicaid agencies have been implementing value-based payment (VBP) models for the last decade and are increasingly exploring advanced population-based payment (PBP) models that increase flexibility, predictability, and accountability for participating provider organizations. PBP models show promise in advancing Medicaid priorities, but are still in the early stages of development, and model design and implementation challenges remain. This article from the Center for Health Care Strategies explores the fundamentals of VBP and how PBP - a particular type of payment model - can help Medicaid agencies achieve goals related to care transformation and quality improvement, revenue stability, and controlling cost of care.

Description: Compares the healthcare system of the US to the universal systems of selected other countries. Relies primarily on information compiled annually by The Commonwealth Fund. Will give the reader an understanding of the difference between universal healthcare, socialized medicine, and single-payer healthcare and how various national systems fall within these categories.

Description: The presenters will discuss recent regulatory changes that allow some long-term care benefits to be included in Medicare Advantage plans. Hear an overview of what has become available in the market and what might happen in the near future.

Description: Rising drug—and, to a lesser extent, health care—costs in Canada are creating long-term challenges for not only governments and employers across Canada but for individuals as well, with no easy answers.

Description: Update on the SOA Health Section's Public Health Task Force's comment on Health People 2030.

Description: Feature article discussing the high cost of prescription medicines in Canada.

Description: The article describes the Health Sections strategic initiative for Public Health and the role of the actuary.